Tirzepatide Raw Material, GIP/GLP-1 Dual Agonist

Tirzepatide is a first‑in‑class GIP/GLP‑1 dual receptor agonist, a long‑acting fatty acid‑modified peptide with long half‑life and high bioavailability. It activates both GLP‑1 and GIP pathways, delivering powerful glycemic control and significant weight loss. It suppresses appetite, delays gastric emptying, reduces visceral fat and improves insulin sensitivity. Widely used for type 2 diabetes, obesity/overweight management and metabolic syndrome. High purity, good stability and compatibility, ideal peptide raw material for pharmaceuticals and aesthetic medicine.